Tinzaparin (Leo): Clinical Trials

2 trials of Tinzaparin (Leo), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting. 1 Not applicable, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable1Not yet recruiting 1
Phase 31Completed 1

Follow Tinzaparin (Leo): new trials by email Literature Review of Tinzaparin (Leo) trials Research Report on Tinzaparin (Leo)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The OAT Trail: The Obesity Anti-Coagulation Thromboprophylaxis Trial.
Anti-Xa Activity Monitoring, Tinzaparin (Leo), enoxaparin - Bariatric Surgery, Anti-Xa Activity
Not applicableNot yet recruitingUniversity College Dublin1802026-08-012026-05-18
Evaluation of Long-Term Sequelae After Thrombophlebitis, i.e. Deep Venous Thrombosis of the Lower Extremities
unfractionated heparin, Tinzaparin (Leo) - Deep Venous Thrombosis
Phase 3CompletedAalborg University Hospital991993-10-012008-03-05

Conditions studied

Obesity (1)  ·  Overweight (1)  ·  Postthrombotic Syndrome (1)  ·  Venous Thromboembolism (1)  ·  Venous Thrombosis (1)

Sponsors

Aalborg University Hospital (1)  ·  University College Dublin (1)

Countries

Denmark (1)  ·  Ireland (1)

Top investigators

Benedicte Laursen, MD, DMSc (1)  ·  Helen M Heneghan, PhD, FRCSI (1)

Results publications

PMID 11867132, PMID 14987333, PMID 18086925, PMID 19036065, PMID 19458109, PMID 20332509, PMID 20622663, PMID 22315264, PMID 23303884, PMID 24141714, PMID 26868660, PMID 28930514, PMID 30121858, PMID 32202076, PMID 34896011